Glioblastoma is the most aggressive brain cancer, carrying a five-year survival rate of just 7% due to hidden cancer cells and the blood-brain barrier. Now, researchers at the University of Technology Sydney, Harvard, and Henan universities have created a single nanoparticle platform published in Science Translational Medicine that tackles both challenges.
Key Highlights
- Precision Guidance: Activated by near-infrared light, the nanoparticles cross the blood-brain barrier and light up tumor clusters as small as 44 micrometers, far outperforming current imaging tools.
- Post-Operative Destruction: Remaining in the surgical cavity, the material uses light and platinum atoms to break down the tumor's protective low-oxygen environment, generating heat and reactive molecules that wipe out lingering microscopic cells.
- Striking Results: In mouse trials, the double-punch therapy completely prevented tumor recurrence, achieving 100% survival at 60 days with zero neurological impairment.
While the therapy must still be proven at human scale, it marks a major step toward preventing glioblastoma recurrence.
Source: Science Daily
